NEWS

The Fast & Neuro interview with Dr. Paul Bhogal

Noncontrast CT vs CT Perfusion or MRI Imaging...

A complex right MCA bifurcation aneurysm

The CLEVER Study – continued evolution of a trusted device

FRED X surface treatment impact on future INR strategies

Day 3 report of LINNC Paris 2022!

25 years of discussions for the INR community

LINNC Paris 2022 – DAY 1

Percutaneous embolization of a lymphatic sac tumor

Vesalio announces oversubscribed class A financing

Nashville, TN – (May 18, 2022) – Vesalio, an emerging leader in improving outcomes in patients with vascular occlusion, is proud to announce it has oversubscribed its Class A financing round. Solas BioVentures led the investment with participation by new and existing investors, including the recent addition of Orlando Health Ventures.